The present invention provides a method of inhibiting the growth of or promoting differentiation and destruction of cancer stem cells (CSCs) comprising contacting the cancer stem cells with a compound of the invention, including CMC2.24, or a pharmaceutically acceptable salt thereof. The present invention also provides a method of down-regulating cancer stem cell-relevant transcription factors comprising contacting the cancer stem cells with a compound of the invention, including CMC2.24, or a pharmaceutically acceptableLa présente invention concerne un procédé dinhibition de la croissance ou de promotion de la différenciation et de la destruction de cellules souches cancéreuses (CSC), comportant la mise en contact des cellules souches cancéreuses avec un composé ayant la structure ou un sel de qualité pharmaceutique de celui-ci.
